Background: Pediatric cancer patients are at high risk for life-threatening infections, therapy associated complications and cancer-related side effects. Exercise is a promising tool to support the immune system and reduce inflammation. The primary objective of this systematic review was to evaluate the effects of exercise interventions in pediatric cancer patients and survivors on the immune system.Methods: For this systematic review (PROSPERO ID: CRD42021194282) we searched four databases (MEDLINE, Cochrane Library, ClinicalTrials.gov, SPORTDiscus) in June 2021. Studies with pediatric patients with oncological disease were included as main criterion. Two authors independently performed data extraction, risk of bias assessment, descriptive analysis and a direction ratio was calculated for all immune cell parameters.Findings: Of the 1448 detected articles, eight studies with overall n = 400 children and adolescents with cancer and n = 17 healthy children as controls aged 4-19 years met the inclusion criteria. Three randomized, four non-randomized controlled trials and one case series were analyzed descriptively. The exercise interventions had no negative adverse effects on the immune system. Statistically significant results indicated enhanced cytotoxicity through exercise, while changes in immune cell numbers did not differ significantly. Interventions further reduced days of in-hospitalization and reduced the risk of infections. Several beneficial direction ratios in immune parameters were identified favoring the intervention group.Interpretation: Exercise interventions for pediatric cancer patients and survivors had no negative but promising beneficial effects on the immune system, especially regarding cytotoxicity, but data is very limited. Further research should be conducted on the immunological effects of different training modalities and intensities, during various treatment phases, and for different pediatric cancer types. The direction ratio parameters given here may provide useful guidance for future clinical trials.Systemic Review Registration: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021194282, Prospero ID: CRD42021194282.
Exercise programs for young people after cancer are not part of regular oncological care. This study describes and evaluates a regional outdoor exercise program and presents data with regard to the promoting and inhibiting factors for participation among pediatric cancer survivors. Exercise options, number of participants, and the cohort were evaluated descriptively for one year. A self-developed questionnaire was used to evaluate satisfaction, mood, motivations, and barriers to exercise. Overall N = 26 survivors (14.6 ± 5.5 years) participated in at least one activity in 2019 including try-out days (N = 10) and active weekend camps (N = 2). No adverse events occurred in 302 physical activity hours. Twenty-one survivors participated in the survey. The largest motivational aspect to participate was “to try out a new sport” (83.9%). Survivors reported “good mood”, and ‘being happy’ after exercising. The largest barrier was concern about ‘not being able to keep up with others’ (38.1%). Around one-third (try-out day) and 50% (active weekend camp) of survivors did not feel confident to continue exercising outside the supervised exercise oncology program. This survey shows high enthusiasm for this exercise program with different outdoor activities and suggests that similar interventions may be accepted by this population.
Objective: The study investigated the response of immune cells, particularly natural killer (NK) cells and innate lymphoid cells (ILCs), to acute exercise in adolescents and young adults (AYAs) undergoing cancer treatment, to lower their treatment burden and evaluate the value of exercise in this vulnerable cohort. Methods: An AYA cancer patient group (PG) (n = 20, 25 ± 7 years old) and an age-matched healthy control group (HG) (n = 20, 27 ± 5 years old) completed a twenty-minute high intensity interval training (HIIT) on a bicycle ergometer. Blood was taken at three timepoints during the intervention. Once immediately before (T0), once immediately after the intervention (T1), and after one-hour of recovery (T2). NK cells, ILCs, respectively their subpopulations, were determined by flow cytometry. Results: Total NK cells (PG: p = 0.023; HG: p = 0.004), CD56dimNK cells (PG: p = 0.035; HG: p = 0.004), total ILCs (PG: p < 0.001; HG: p < 0.001), ILC1-like (PG: p = 0.001; HG: p = 0.004), ILC2 (PG: p = 0.006; HG: p = 0.003) and innate lymphoid cell precursors (ILCPs) (PG: p = 0.009; HG: p = 0.002) increased significantly from T0 to T1. CD56brightNK cells (HG: p = 0.011) increased significantly only in the HG. From T1 to T2 total NK cells (PG: p < 0.001; HG: p < 0.001), CD56dimNK cells (PG: p < 0.001; HG: p < 0.001), CD56brightNK cells (PG: p < 0.001; HG: p < 0.001), ILC2 (PG: p = 0.035; HG: p = 0.007) and ILCPs (PG: p = 0.006; HG: p = 0.003) decreased significantly. ILC1-like maintained their elevated cell count plateau during the recovery phase. No significant differences were found for NKp44+ILC3 and for inter-group comparisons regarding the percentage changes of cell counts from T0 to T1 or T1 to T2. Younger age and higher heart rates (in percentage of age-predicted maximal heart rate) during the intervention were associated with an increased mobilization of immune cells, especially in NK cells and their subpopulations. Conclusion: We were able to show, that HIIT enhances the mobilization of NK cells and ILCs to the same extend in AYA cancer patients than in healthy controls. Our pilot study revealed, that exercise is likely to play an important role in the defense against pathogens and neoplastic cells and that AYA cancer patients might benefits from regular exercise programs during anti-cancer treatment. Trial registration: : The study was registered on 13.11.2022, registration number NCT05656651, in the international register of clinical trials https://www.clinicaltrials.gov/.
(1) Background: Growing evidence indicates benefits through exercise programs in pediatric oncology throughout the whole cancer trajectory. This should include palliative care, too. This project analyzes the feasibility of a supervised exercise program offered during hospital and home-based care for children with advanced cancer diagnoses. (2) Methods: Four children (7–13 years old) with advanced cancer diagnoses participated in this project. It consisted of supervised exercise sessions offered once a week (30–90 min), mainly home-based, but also on an in- and outpatient basis. Regular data assessments included psychological and physical capacity-related endpoints and body composition. Details and contents of exercise sessions and adverse events were recorded. (3) Results: Exercise was feasible with 73 ± 9% adherence to the minimum number of planned sessions. The exercise offer was accepted until shortly before death. Effects on fatigue, quality of life and muscular endurance were noted. Participants showed major deviations from age-specific reference values. No exercise-related adverse events occurred. (4) Conclusions: The exercise program was safe, feasible, and might have served as a supportive tool to reduce overall burden. Evaluation of exercise as usual palliative care should be assessed by further studies.
13 June 2024 in BMJ Open Sport & Exercise Medicine
Objectives Paediatric patients with cancer undergoing allogeneic haematopoietic stem cell transplantation (allo-HSCT) face a high risk for life-threatening infections and transplant-related complications. Therefore, these children should be in the best possible physical condition beforehand. The study aims to evaluate the fitness status before allo-HSCT and identify correlations between fitness, quality of life and fatigue, clinical data, and previous exercise sessions. Methods Paediatric patients with cancer ≥4 years old, treated with allo-HSCT, were recruited for the ANIMAL trial ("Effects of a low vs. moderate intense exercise program on immune recovery during paediatric allo-HSCT.", DRKS ID:DRKS00019865). Assessed at admission for HSCT were (1) clinical and anthropometric data, (2) motor performance (strength, endurance and balance) and (3) psychological parameters. Values were compared with published reference values (normative data from the literature) of healthy children, and correlation analyses were conducted. Results 22 paediatric patients undergoing pre-allo-HSCT (23% female, 9.4±4.5 years, 73% leukaemia) exhibited substantial reduced differences in all motor performance parameters, with up to −106%±98 (mean difference to reference value) in static stance, −37%±45 in sit-to-stand, −52%±16 in leg extension and −48%±22 in hand grip strength compared with reference values. Correlations were observed among age and fitness parameters, the number of inpatient days and fatigue, and many previous exercise sessions correlated with better hand grip strength. Conclusion These results indicate a poorer fitness status in children before HSCT compared with healthy children, recommending the need for structured exercise programmes for children undergoing HSCT. Differently directed correlations between age/body mass index and endurance/strength and between exercise sessions and strength show the importance of individualised training recommendations and the effect of training.
Objectives: Pediatric cancer patients undergoing allogeneic hematopoietic stem cell transplantation (allo‐HSCT) are severely immunosuppressed leading to a high risk for life‐threatening infections. This trial investigates the effects of exercise during allo‐HSCT on immune cell recovery and patient‐related outcomes (DRKS00019865).Methods: Twenty‐two pediatric cancer patients (≥4 years) undergoing allo‐HSCT were randomized into an intervention group with moderate to high intensity training (IGhigh) and an intervention group with low intensity training (IGlow). Supervised and individualized exercise sessions were scheduled three to five times per week during hospitalization. The primary outcome was the quantity of NK cells 30 days after HSCT. Further, feasibility and safety of the intervention, physical fitness, fatigue, quality of life (QoL), transplant‐related metrics, and clinical data were assessed.Results: At Day +30, the median NK cell count was more than twice as high in the IGhigh compared to the IGlow (n.s., 208.45/µL vs. 99.12/µL). Subset analysis revealed that CD16+ CD56dim NK cells and NKp44+ CD56dim NK cells were higher in the IGhigh on Day +30 (p = 0.043 and p = 0.061, respectively). In contrast, the IGlow exhibited higher levels of NKp44− circulating innate lymphoid cells (cILC3) on Day +15 (p = 0.045). As expected, the IGhigh showed significant increases in leg strength compared to the IGlow. All participants experienced a decline in QoL and fatigue.Conclusion: This pilot study implied a trend toward improved immune recovery with moderate to vigorous exercise. Importantly, both programs were safe and feasible. The higher intensity intervention showed significant benefits on leg strength and specific innate immune cell populations, but these findings must be considered preliminary in the context of the exploratory nature of the study.